BACKGROUND: Live vaccines including BCG and measles may have non-targeted beneficial effects on childhood survival in areas with high mortality. The authors therefore undertook a survey of vaccinia scars to evaluate subsequent mortality. SUBJECTS: Based on a population census, a cohort of 1893 adults in urban Guinea-Bissau was examined in 1998 and followed until 2002. MAIN OUTCOME MEASURE: All cause mortality, excluding accidents. RESULTS: The median age of vaccinia vaccinations had been 16-18 years. Adults with a vaccinia scar had a mortality ratio (MR) of 0.60 (0.41-0.87) compared to those without any scar. The effect was stronger for women. Mortality decreased with each additional vaccinia scar (MR=0.73 (0.56-0.95)). Among 502 individuals with information on HIV infection, the age-adjusted HIV-2 prevalence was 2.45 (1.06-5.65) for those with a vaccinia scar. Control for district, ethnic group, schooling, place of birth, quality of housing and HIV status had little effect on the estimate. Since vaccinia and BCG scars could have been confused, mortality for adults with vaccinia and/or BCG scar was compared to those without, the MR being 0.61 (0.41-0.89). CONCLUSION: Known cultural or socio-economic factors possibly associated with access to vaccination had no influence on the mortality ratio for having a vaccinia scar. Hence, vaccinia vaccination may have a prolonged beneficial effect on adult survival.
BACKGROUND: Live vaccines including BCG and measles may have non-targeted beneficial effects on childhood survival in areas with high mortality. The authors therefore undertook a survey of vaccinia scars to evaluate subsequent mortality. SUBJECTS: Based on a population census, a cohort of 1893 adults in urban Guinea-Bissau was examined in 1998 and followed until 2002. MAIN OUTCOME MEASURE: All cause mortality, excluding accidents. RESULTS: The median age of vaccinia vaccinations had been 16-18 years. Adults with a vaccinia scar had a mortality ratio (MR) of 0.60 (0.41-0.87) compared to those without any scar. The effect was stronger for women. Mortality decreased with each additional vaccinia scar (MR=0.73 (0.56-0.95)). Among 502 individuals with information on HIV infection, the age-adjusted HIV-2 prevalence was 2.45 (1.06-5.65) for those with a vaccinia scar. Control for district, ethnic group, schooling, place of birth, quality of housing and HIV status had little effect on the estimate. Since vaccinia and BCG scars could have been confused, mortality for adults with vaccinia and/or BCG scar was compared to those without, the MR being 0.61 (0.41-0.89). CONCLUSION: Known cultural or socio-economic factors possibly associated with access to vaccination had no influence on the mortality ratio for having a vaccinia scar. Hence, vaccinia vaccination may have a prolonged beneficial effect on adult survival.
Authors: Anna Gil; Laurie L Kenney; Rabinarayan Mishra; Levi B Watkin; Nuray Aslan; Liisa K Selin Journal: Trans R Soc Trop Med Hyg Date: 2015-01 Impact factor: 2.184
Authors: Valerie Acm Koeken; L Charlotte J de Bree; Vera P Mourits; Simone Jcfm Moorlag; Jona Walk; Branko Cirovic; Rob Jw Arts; Martin Jaeger; Helga Dijkstra; Heidi Lemmers; Leo Ab Joosten; Christine S Benn; Reinout van Crevel; Mihai G Netea Journal: J Clin Invest Date: 2020-10-01 Impact factor: 14.808
Authors: A Diouf; H Trottier; T J Youbong; N F Ngom-Guéye; O Ndiaye; A Seck; D Sarr; S Diop; M Seydi; S Mboup; V K Nguyen; A Jaye Journal: Epidemiol Infect Date: 2017-12-13 Impact factor: 2.451
Authors: Bastiaan A Blok; Kristoffer J Jensen; Peter Aaby; Anders Fomsgaard; Reinout van Crevel; Christine S Benn; Mihai G Netea Journal: Eur J Clin Microbiol Infect Dis Date: 2019-02-05 Impact factor: 5.103
Authors: Mette Lundsby Jensen; Sangeeta Dave; Maarten Schim van der Loeff; Carlos da Costa; Tim Vincent; Aleksandra Leligdowicz; Christine Stabell Benn; Adam Roth; Henrik Ravn; Ida Maria Lisse; Hilton Whittle; Peter Aaby Journal: PLoS One Date: 2006-12-20 Impact factor: 3.240
Authors: Osman Sankoh; Paul Welaga; Cornelius Debpuur; Charles Zandoh; Stephney Gyaase; Mary Atta Poma; Martin Kavao Mutua; S M Manzoor Ahmed Hanifi; Cesario Martins; Eric Nebie; Moubassira Kagoné; Jacques B O Emina; Peter Aaby Journal: Int J Epidemiol Date: 2014-05-30 Impact factor: 7.196